The Discounted Cash Flow (DCF) valuation of TG Therapeutics Inc (TGTX) is 43.99 USD. With the latest stock price at 49.28 USD, the upside of TG Therapeutics Inc based on DCF is -10.7%.
Based on the latest price of 49.28 USD and our DCF valuation, TG Therapeutics Inc (TGTX) is a sell. selling TGTX stocks now will result in a potential gain of 10.7%.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 12.0% | 9.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 27.10 - 111.26 | 43.99 |
| Upside | -45.0% - 125.8% | -10.7% |